Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia
For the treatment of dementia and Alzheimer’s disease, acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) and/or the non-competitive inhibitor of N-methyl-D-aspartate receptors (NMDA receptors) memantine are currently used. The administration of these drugs can help temporarily i...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2019-12-01
|
| Series: | Безопасность и риск фармакотерапии |
| Assuntos: | |
| Acceso en liña: | https://www.risksafety.ru/jour/article/view/154 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|